I
ImmunoMet Therapeutics
And commercializes oncology products for cancer patients
About ImmunoMet Therapeutics
ImmunoMet Therapeutics is a biotechnology company focused on developing innovative therapies by harnessing cellular metabolism. The company operates in the healthcare sector, specifically targeting metabolic reprogramming to treat fibrosis and oncology. ImmunoMet's business model revolves around research and development, with a strong emphasis on creating novel treatments that address unmet medical needs in these therapeutic areas. The company generates revenue through partnerships, licensing agreements, and securing funding from investors. ImmunoMet serves a diverse range of clients, including healthcare providers, research institutions, and pharmaceutical companies. The market it operates in is highly specialized, focusing on advanced medical treatments and biotechnological innovations. By leveraging cutting-edge research and strategic collaborations, ImmunoMet aims to bring transformative therapies to market, improving patient outcomes and advancing the field of medical science.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Dexter, United States
- Sector
- Biotech & Life Sciences
News
Open roles
ImmunoMet Therapeutics in the Dexter ecosystem
The ImmunoMet Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Mirae Asset Venture Investment
NHN Investment
Sungwuk Kim
SL Investment
InterVest
G.N. Tech Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ImmunoMet Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ImmunoMet Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


